Toggle Sidebar
Home
AI Agent
Annotations
Files
Pricing and plans
Help
Blog
About
Contact us
API
MCP
Terms of service
Privacy policy
Get the full experience
We save the real magic for signed-in users.
Sign In
Home
Stock Screener
Document Search
Charting
Watchlists
Recent Filings
Exagen Inc.
(XGN US)
$5.26
-1.84
25.92%
Ext:
$5.42
+0.16
3.01%
(After Hours ยท 22:12:26 UTC)
Follow
Doc Search
Profile
Entity Structure
SEC Filings
Financials
Charting
Short Interest
Employees
Toggle Sidebar
Home
AI Agent
Annotations
Files
Pricing and plans
Help
Blog
About
Contact us
API
MCP
Terms of service
Privacy policy
Get the full experience
We save the real magic for signed-in users.
Sign In
Home
Stock Screener
Document Search
Charting
Watchlists
Recent Filings
Exagen Inc.
(XGN US)
$5.26
-1.84
25.92%
Ext:
$5.42
+0.16
3.01%
(After Hours ยท 22:12:26 UTC)
Follow
Doc Search
Profile
Entity Structure
SEC Filings
Financials
Charting
Short Interest
Employees
XGN US
โ
Ask AI
XGN US
โ
Ask AI
SEC Filings
SEC Filings
Select Filings
Financials
(32)
Expand
10-Q
Q3
ended 30 Sept 2026
09:01AM
10-Q
Q2
ended 30 Jun 2026
4 Aug
10-Q
Q1
ended 31 Mar 2026
11 May
10-K
FY 2025
ended 31 Dec 2025
10 Mar
10-Q
Q3
ended 30 Sept 2025
4 Nov 2025
10-Q
Q2
ended 30 Jun 2025
29 Jul 2025
10-Q
Q1
ended 31 Mar 2025
5 May 2025
10-K
FY 2024
ended 31 Dec 2024
11 Mar 2025
10-Q
Q3
ended 30 Sept 2024
12 Nov 2024
10-Q
Q2
ended 30 Jun 2024
5 Aug 2024
10-Q
Q1
ended 31 Mar 2024
13 May 2024
10-K
FY 2023
ended 31 Dec 2023
18 Mar 2024
10-Q
Q3
ended 30 Sept 2023
13 Nov 2023
10-Q
Q2
ended 30 Jun 2023
7 Aug 2023
10-Q
Q1
ended 31 Mar 2023
15 May 2023
Events
(76)
Expand
8-K
Results of Operations and Financial Condition
07:33AM
8-K
Results of Operations and Financial Condition
4 Aug
8-K
Submission of Matters to a Vote of Security Holders
9 Jun
8-K
Results of Operations and Financial Condition
11 May
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
23 Apr
8-K
Results of Operations and Financial Condition
10 Mar
8-K
Results of Operations and Financial Condition
12 Jan
8-K
Results of Operations and Financial Condition
4 Nov 2025
8-K
Results of Operations and Financial Condition
29 Jul 2025
8-K
Director/Officer Changes & Compensatory Arrangements
17 Jul 2025
8-K
Submission of Matters to Shareholder Vote
11 Jun 2025
8-K
Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of
9 May 2025
8-K
Exagen Inc. Announces Proposed Public Offering of Common Stock
8 May 2025
8-K
Results of Operations and Financial Condition
5 May 2025
8-K
Exagen Inc. Announces Senior Secured Credit Facility with Perceptive Advisors
28 Apr 2025
Insider Ownership
(165)
Expand
Form 4
Nova Tina Susan
2 Nov
Form 4
Chernett Jorey
20 Oct
Form 4
ABALLI JOHN
19 Oct
Form 3
Chernett Jorey
19 Oct
Form 4
Black Jeffrey G.
2 Sep
Form 4/A
Robertson Bruce C
24 Aug
Form 4
Robertson Bruce C
19 Aug
Form 4
Kim Paul
19 Aug
Form 4
KAHN SCOTT D
22 Jun
Form 4
McKhann Chas
22 Jun
Form 4
Stokes Frank
22 Jun
Form 3/A
McKhann Chas
21 Apr
Form 3
McKhann Chas
16 Mar
Form 4
Black Jeffrey G.
16 Mar
Form 4
ABALLI JOHN
16 Mar
Beneficial Ownership
(49)
Expand
SC 13G
EXAGEN INC.
27 May
SC 13G/A
EXAGEN INC.
20 May
SC 13G/A
EXAGEN INC.
17 Feb
SC 13G/A
EXAGEN INC.
11 Feb
SC 13G
EXAGEN INC.
4 Feb
SC 13G/A
EXAGEN INC.
14 Aug 2025
SC 13G/A
EXAGEN INC.
14 Aug 2025
SC 13G/A
EXAGEN INC.
12 May 2025
SC 13G/A
EXAGEN INC.
17 Apr 2025
SC 13G/A
EXAGEN INC.
29 Jan 2025
SC 13G/A
EXAGEN INC.
12 Dec 2024
SC 13G/A
EXAGEN INC.
14 Feb 2024
SC 13G/A
EXAGEN INC.
14 Feb 2024
SC 13G/A
EXAGEN INC.
13 Feb 2024
SC 13G/A
EXAGEN INC.
13 Feb 2024
Other Ownership
(2)
Expand
Form 144
Adawi Kamal
8 Oct 2024
Form 144
Adawi Kamal
9 Aug 2024
Proxies
(19)
Expand
ARS
Annual report to security holders
27 Apr
DEFA14A
Definitive additional materials
27 Apr
DEF 14A
Definitive proxy statement
27 Apr
ARS
Annual report to security holders
30 Apr 2025
DEFA14A
Definitive additional materials
30 Apr 2025
DEF 14A
Definitive proxy statement
30 Apr 2025
DEFA14A
Definitive additional materials
26 Apr 2024
ARS
Annual report to security holders
26 Apr 2024
DEF 14A
Definitive proxy statement
26 Apr 2024
DEFA14A
Definitive additional materials
24 May 2023
ARS
Annual report to security holders
28 Apr 2023
DEFA14A
Definitive additional materials
28 Apr 2023
DEF 14A
Definitive proxy statement
28 Apr 2023
DEFA14A
Definitive additional materials
28 Apr 2022
DEF 14A
Definitive proxy statement
28 Apr 2022
Registrations
(40)
Expand
S-3
Registration statement (primary offering)
09:33AM
S-8
Registration statement (employee benefit plan)
12 May
S-3
Registration statement (primary offering)
20 Jun 2025
S-8
Registration statement (employee benefit plan)
20 May 2025
424B5
Prospectus filing (Rule 424(b)(5))
8 May 2025
424B5
Prospectus filing (Rule 424(b)(5))
7 May 2025
S-8
Registration statement (employee benefit plan)
13 May 2024
424B5
Prospectus filing (Rule 424(b)(5))
29 Nov 2023
S-3/A
Registration statement (primary offering, amendment)
27 Nov 2023
424B5
Prospectus filing (Rule 424(b)(5))
20 Nov 2023
S-3
Registration statement (primary offering)
17 Nov 2023
S-8
Registration statement (employee benefit plan)
18 May 2023
424B5
Prospectus filing (Rule 424(b)(5))
15 Sep 2022
S-8
Registration statement (employee benefit plan)
11 May 2022
S-8
Registration statement (employee benefit plan)
11 May 2021
Filing Review Correspondence
(8)
Expand
UPLOAD
Filing review upload
30 Jun 2025
CORRESP
Filing review correspondence
30 Jun 2025
CORRESP
Filing review correspondence
28 Nov 2023
CORRESP
Filing review correspondence
17 Nov 2020
CORRESP
Filing review correspondence
16 Sep 2019
CORRESP
Filing review correspondence
16 Sep 2019
CORRESP
Filing review correspondence
26 Aug 2019
DRSLTR
Filing review correspondence (DRSLTR)
14 Jun 2019
SEC Orders And Notices
(4)
Expand
EFFECT
Notice of effectiveness
2 Jul 2025
EFFECT
Notice of effectiveness
29 Nov 2023
EFFECT
Notice of effectiveness
19 Nov 2020
EFFECT
Notice of effectiveness
18 Sep 2019
Exempt Offerings
(25)
Expand
D
06b
1 Feb 2019
D
06b
18 May 2017
D
06b
10 Apr 2017
D
06b
9 Mar 2017
D
06b
1 Feb 2017
D
06b
19 Dec 2016
D
06b
10 Nov 2016
D
06b
11 Oct 2016
D
06b
30 Aug 2016
D
06b
24 Jun 2016
D
06b
26 Jan 2016
D
06b
21 Oct 2015
D
06b
6 Jul 2015
D
06b
1 Apr 2015
D
06b
21 Jul 2014
Other
(1)
Expand
CERT
CERT
17 Sep 2019
Select Filings
Financials
(32)
Expand
10-Q
Q3
ended 30 Sept 2026
09:01AM
10-Q
Q2
ended 30 Jun 2026
4 Aug
10-Q
Q1
ended 31 Mar 2026
11 May
10-K
FY 2025
ended 31 Dec 2025
10 Mar
10-Q
Q3
ended 30 Sept 2025
4 Nov 2025
10-Q
Q2
ended 30 Jun 2025
29 Jul 2025
10-Q
Q1
ended 31 Mar 2025
5 May 2025
10-K
FY 2024
ended 31 Dec 2024
11 Mar 2025
10-Q
Q3
ended 30 Sept 2024
12 Nov 2024
10-Q
Q2
ended 30 Jun 2024
5 Aug 2024
10-Q
Q1
ended 31 Mar 2024
13 May 2024
10-K
FY 2023
ended 31 Dec 2023
18 Mar 2024
10-Q
Q3
ended 30 Sept 2023
13 Nov 2023
10-Q
Q2
ended 30 Jun 2023
7 Aug 2023
10-Q
Q1
ended 31 Mar 2023
15 May 2023
Events
(76)
Expand
8-K
Results of Operations and Financial Condition
07:33AM
8-K
Results of Operations and Financial Condition
4 Aug
8-K
Submission of Matters to a Vote of Security Holders
9 Jun
8-K
Results of Operations and Financial Condition
11 May
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
23 Apr
8-K
Results of Operations and Financial Condition
10 Mar
8-K
Results of Operations and Financial Condition
12 Jan
8-K
Results of Operations and Financial Condition
4 Nov 2025
8-K
Results of Operations and Financial Condition
29 Jul 2025
8-K
Director/Officer Changes & Compensatory Arrangements
17 Jul 2025
8-K
Submission of Matters to Shareholder Vote
11 Jun 2025
8-K
Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of
9 May 2025
8-K
Exagen Inc. Announces Proposed Public Offering of Common Stock
8 May 2025
8-K
Results of Operations and Financial Condition
5 May 2025
8-K
Exagen Inc. Announces Senior Secured Credit Facility with Perceptive Advisors
28 Apr 2025
Insider Ownership
(165)
Expand
Form 4
Nova Tina Susan
2 Nov
Form 4
Chernett Jorey
20 Oct
Form 4
ABALLI JOHN
19 Oct
Form 3
Chernett Jorey
19 Oct
Form 4
Black Jeffrey G.
2 Sep
Form 4/A
Robertson Bruce C
24 Aug
Form 4
Robertson Bruce C
19 Aug
Form 4
Kim Paul
19 Aug
Form 4
KAHN SCOTT D
22 Jun
Form 4
McKhann Chas
22 Jun
Form 4
Stokes Frank
22 Jun
Form 3/A
McKhann Chas
21 Apr
Form 3
McKhann Chas
16 Mar
Form 4
Black Jeffrey G.
16 Mar
Form 4
ABALLI JOHN
16 Mar
Beneficial Ownership
(49)
Expand
SC 13G
EXAGEN INC.
27 May
SC 13G/A
EXAGEN INC.
20 May
SC 13G/A
EXAGEN INC.
17 Feb
SC 13G/A
EXAGEN INC.
11 Feb
SC 13G
EXAGEN INC.
4 Feb
SC 13G/A
EXAGEN INC.
14 Aug 2025
SC 13G/A
EXAGEN INC.
14 Aug 2025
SC 13G/A
EXAGEN INC.
12 May 2025
SC 13G/A
EXAGEN INC.
17 Apr 2025
SC 13G/A
EXAGEN INC.
29 Jan 2025
SC 13G/A
EXAGEN INC.
12 Dec 2024
SC 13G/A
EXAGEN INC.
14 Feb 2024
SC 13G/A
EXAGEN INC.
14 Feb 2024
SC 13G/A
EXAGEN INC.
13 Feb 2024
SC 13G/A
EXAGEN INC.
13 Feb 2024
Other Ownership
(2)
Expand
Form 144
Adawi Kamal
8 Oct 2024
Form 144
Adawi Kamal
9 Aug 2024
Proxies
(19)
Expand
ARS
Annual report to security holders
27 Apr
DEFA14A
Definitive additional materials
27 Apr
DEF 14A
Definitive proxy statement
27 Apr
ARS
Annual report to security holders
30 Apr 2025
DEFA14A
Definitive additional materials
30 Apr 2025
DEF 14A
Definitive proxy statement
30 Apr 2025
DEFA14A
Definitive additional materials
26 Apr 2024
ARS
Annual report to security holders
26 Apr 2024
DEF 14A
Definitive proxy statement
26 Apr 2024
DEFA14A
Definitive additional materials
24 May 2023
ARS
Annual report to security holders
28 Apr 2023
DEFA14A
Definitive additional materials
28 Apr 2023
DEF 14A
Definitive proxy statement
28 Apr 2023
DEFA14A
Definitive additional materials
28 Apr 2022
DEF 14A
Definitive proxy statement
28 Apr 2022
Registrations
(40)
Expand
S-3
Registration statement (primary offering)
09:33AM
S-8
Registration statement (employee benefit plan)
12 May
S-3
Registration statement (primary offering)
20 Jun 2025
S-8
Registration statement (employee benefit plan)
20 May 2025
424B5
Prospectus filing (Rule 424(b)(5))
8 May 2025
424B5
Prospectus filing (Rule 424(b)(5))
7 May 2025
S-8
Registration statement (employee benefit plan)
13 May 2024
424B5
Prospectus filing (Rule 424(b)(5))
29 Nov 2023
S-3/A
Registration statement (primary offering, amendment)
27 Nov 2023
424B5
Prospectus filing (Rule 424(b)(5))
20 Nov 2023
S-3
Registration statement (primary offering)
17 Nov 2023
S-8
Registration statement (employee benefit plan)
18 May 2023
424B5
Prospectus filing (Rule 424(b)(5))
15 Sep 2022
S-8
Registration statement (employee benefit plan)
11 May 2022
S-8
Registration statement (employee benefit plan)
11 May 2021
Filing Review Correspondence
(8)
Expand
UPLOAD
Filing review upload
30 Jun 2025
CORRESP
Filing review correspondence
30 Jun 2025
CORRESP
Filing review correspondence
28 Nov 2023
CORRESP
Filing review correspondence
17 Nov 2020
CORRESP
Filing review correspondence
16 Sep 2019
CORRESP
Filing review correspondence
16 Sep 2019
CORRESP
Filing review correspondence
26 Aug 2019
DRSLTR
Filing review correspondence (DRSLTR)
14 Jun 2019
SEC Orders And Notices
(4)
Expand
EFFECT
Notice of effectiveness
2 Jul 2025
EFFECT
Notice of effectiveness
29 Nov 2023
EFFECT
Notice of effectiveness
19 Nov 2020
EFFECT
Notice of effectiveness
18 Sep 2019
Exempt Offerings
(25)
Expand
D
06b
1 Feb 2019
D
06b
18 May 2017
D
06b
10 Apr 2017
D
06b
9 Mar 2017
D
06b
1 Feb 2017
D
06b
19 Dec 2016
D
06b
10 Nov 2016
D
06b
11 Oct 2016
D
06b
30 Aug 2016
D
06b
24 Jun 2016
D
06b
26 Jan 2016
D
06b
21 Oct 2015
D
06b
6 Jul 2015
D
06b
1 Apr 2015
D
06b
21 Jul 2014
Other
(1)
Expand
CERT
CERT
17 Sep 2019
Ask in Filing
Ask in Filing